Navigation Links
AutismOne 2018 Conference Asks, “Is Suramin the Answer the Autism Community Has Been Waiting For?”
Date:8/7/2017

AutismOne today announced that at the 2018 event, Dr. Judy Mikovits will explain complicated details of how retroviruses in today’s biological therapeutics, including vaccines, are contributing to autoimmune disease, neuroimmune disease, and cancer, chronic inflammatory diseases that have been skyrocketing in incidence in the past quarter century. Dr. Mikovits has spent her adult life studying how retroviruses contribute to these diseases. Many factors are important in the development of diseases associated with retroviruses, such as the expression and mode of transmission being key to disease development. Dr. Mikovits has learned a great deal about the types of diseases from approximately 40 years of study.

Suramin is an old drug with 75 years of use in humans, and suramin was known to be a potent antiretroviral before HIV was isolated. Dr. Mikovits worked for more than 20 years at the National Cancer Institute (NCI) developing treatments for retroviral associated cancers and HIV/AIDS. She led the Lab of Antiviral Drug Mechanisms of the National Cancer Institute’s Developmental Therapeutics branch. Dr. Mikovits first worked on suramin in the Biological Response Modifiers Program of the NCI between 1983 and 1987, at which time it was found to have potent antiretroviral activity against HIV. Interestingly, suramin was shown to be most potent against the murine leukemia virus-related retroviruses in 1979 and 1986.[1, 2] Dr. Mikovits started her work with this knowledge in HTLV-1 in 1980 before there was an HIV or AIDS.

May 23-27, 2018, is the time for the event titled AutismOne 2018 Conference: Say “YES” to Recovery, which will be held in Chicagoland at the beautiful Westin Lombard. Attendees of the AutismOne 2018 Conference will hear about how suramin has had positive effects for those with autism and other conditions.

For more information and to register, please visit http://www.autismone.org.

References
1.    De Clercq, E. (1979). Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses. Cancer Letters, 8(1), 9-22. doi:10.1016/0304-3835(79)90017-x
2.    De Clercq, E. (1987). Suramin in the treatment of AIDS: Mechanism of action. Antiviral Research, 7(1), 1-10. doi:10.1016/0166-3542(87)90034-9

Read the full story at http://www.prweb.com/releases/2017/08/prweb14577077.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. AutismOne Announces Featured Speaker Robert J. Krakow, Esq., Keynotes Robert F. Kennedy, Jr. and Dr. Suzanne Humphries, and Vax/Unvax Study Author Dr. Anthony Mawson
2. AutismOne Announces Board Certified in Integrative Pediatrics (BCIP) credential offered through American Association of Integrative Medicine in Colorado Springs
3. AutismOne Announces Treating ADHD Naturally Event: First Time Ever in Colorado
4. Robert F. Kennedy, Jr., Chairman of the World Mercury Project, to be featured at AutismOne 2017 Conference
5. Emmy Award-Winner and Producer Del Bigtree Joins VAXXED Documentary Panel at AutismOne 2016 Conference in May
6. VAXXED: FROM COVER-UP TO CATASTROPHE at the AutismOne 2016 Conference
7. Over 150 Speakers on Autism and Related Topics Meet to Help Parents and Professionals at the AutismOne 2016 Conference
8. Self-Advocates with Autism Present at AutismOne 2016 Conference in Chicago
9. Therapies for Autism Presented at AutismOne 2016 Conference with 130 Speakers and Extended Registration Discount
10. Closer to the Cause, Closer to the Cure - Landmark Scientific Research toward Treatment Coming to AutismOne 2016 Conference in Chicago
11. AutismOne Announces Global HPV Advocacy, Continuing Medical Education, and Scientific Medicinal Cannabis Emphases at 2016 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: